Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Endostatin Level as a Marker for Coronary Artery Calcification in Type 2 Diabetic Patients With Coronary Heart Disease

NCT03404037 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT03404037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03404037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Endostatin Level as a Marker for Coronary Artery Calcification in Type 2 Diabetic Patients With Coronary Heart Disease
Lead sponsor
Zagazig University
Phase
Observational
Overall status
Completed
Start date
March 2, 2017
Completion date
December 20, 2017
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arteriosclerosis, coronary artery disease, diabetes mellitus, type 2